Long-term survival of patients diagnosed with non-Hodgkin lymphoma after a previous malignancy

Leukemia and Lymphoma

Volumn 50, Issue 2, 2009, Pages 179-186

  Pulte, Dianne ^a,b   Gondos, Adam ^a   Brenner, Hermann ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Non Hodgkin lymphoma; Prior malignancy; Prognosis; Trends

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; SECOND CANCER; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME; TREND STUDY; UNITED STATES;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; SURVIVAL RATE; TIME FACTORS;

EID: 61349149489     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802645061     Document Type: Article

References (18)

1. Coiffier, B. (2002) Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma. Semin Oncol, 29, pp. 18-22.
2. Pfreundschuh, M., Trumper, L., Osterborg, A., Pettengell, R., Trneny, M. Imrie, K. et al. (2006) CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: A randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol, 7, pp. 379-391.
3. Sehn, L. H., Donaldson, J., Chhanabhai, M., Fitzgerald, C., Gill, K. Klasa, R. et al. (2005) Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol, 23, pp. 5027-5033.
4. Besson, C., Goubar, A., Gabarre, J., Rozenbaum, W., Pialoux, G. Chatelet, F. P. et al. (2001) Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood, 98, pp. 2339-2344.
5. Diamond, C., Taylor, T. H., Im, T., Miradi, M. and Anton-Culver, H. (2006) Improved survival and chemotherapy response among patients with AIDS-related non-Hodgkin's lymphoma receiving highly active antiretroviral therapy. Hematol Oncol, 24, pp. 139-145.
6. Hoffmann, C., Chow, K. U., Wolf, E., Faetkenheuer, G., Stellbrink, H. J. van Lunzen, J. et al. (2004) Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease. Br J Haematol, 125, pp. 455-462.
7. Pettengell, R., Radford, J. A., Morgenstern, G. R., Scarffe, J. H., Harris, M. Woll, P. J. et al. (1996) Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma. J Clin Oncol, 14, pp. 586-592.
8. Rueffer, U., Josting, A., Franklin, J., May, M., Sieber, M. Breuer, K. et al. (2001) Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: Incidence, treatment, and prognosis. J Clin Oncol, 19, pp. 2026-2032.
9. Brenner, H., Gefeller, O. and Hakulinen, T. (2004) Period analysis for 'up-to-date' cancer survival data: Theory, empirical evaluation, computational realisation and applications. Eur J Cancer, 40, pp. 326-335.
10. Brenner, H. and Hakulinen, T. (2006) Up-to-date and precise estimates of cancer patient survival: Model-based period analysis. Am J Epidemiol, 164, pp. 689-696.
11. Brenner, H. and Gefeller, O. (1996) An alternative approach to monitoring cancer patient survival. Cancer, 78, pp. 2004-2010.
12. Brenner, H. and Hakulinen, T. (2002) Up-to-date long-term survival curves of patients with cancer by period analysis. J Clin Oncol, 20, pp. 826-832.
13. Brenner, H., Soderman, B. and Hakulinen, T. (2002) Use of period analysis for providing more up-to-date estimates of long-term survival rates: Empirical evaluation among 370,000 cancer patients in Finland. Int J Epidemiol, 31, pp. 456-462.
14. Ederer, F., Axtell, L. M. and Cutler, S. J. (1961) The relative survival rate: A statistical methodology. Natl Cancer Inst Monogr, 6, pp. 101-121.
15. Henson, D. E. and Ries, L. A. (1995) The relative survival rate. Cancer, 76, pp. 1687-1688.
16. Ederer, F. and Heise, H. (1959) Instructions to IBM 650 programmers in processing survival computations. Methodological Note No. 10, National Cancer Institute, Bethesda, MD
17. Arias, E. (2002) United States life tables, 2000. Natl Vit Stat Rep, 51, pp. 1-39.
18. Krishnan, B. and Morgan, G. J. (2007) Non-Hodgkin lymphoma secondary to cancer chemotherapy. Cancer Epidemiol Biomarkers Prev, 16, pp. 377-380.